Esperion Therapeutics, Inc.
Board Member
2024-05-23–present
Antonio M. Gotto Jr., M.D., D.Phil.
Board Member
Esperion Therapeutics, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Antonio M. Gotto Jr., M.D., D.Phil.
Antonio M. Gotto Jr., M.D., D.Phil. is recorded as Board Member at Esperion Therapeutics, Inc.. Esperion Therapeutics, Inc. reported in an 8-K filed April 1, 2025 that Antonio M. Gotto Jr., M.D., D.Phil. resigned as director, effective June 1, 2025. Esperion Therapeutics, Inc. reported in an 8-K filed May 28, 2024 that Antonio M. Gotto Jr., M.D., D.Phil. was appointed Class II director, effective May 23, 2024.
“On April 1, 2025, Antonio M. Gotto, Jr., M.D., D. Phil. notified the Board of the Company of his decision to resign from the Board, including his position as a member of the Nominating and Corporate Governance Committee of the Board (the "Nominating and Corporate Governance Committee"), effective June 1, 2025.”
“to elect two Class II director nominees, Antonio M. Gotto Jr., M.D., D.Phil., and Nicole Vitullo, to the Company's Board of Directors, each to hold office until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal "Proposal 1"”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Esperion Therapeutics, Inc.
Board Member
SEC 8-K
Current2024-05-23–present
-
Esperion Therapeutics, Inc.
Board Member
SEC 8-K
2024-05-23–2025-06-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.